Press "Enter" to skip to content

Facing headwinds on new Alzheimer’s drug, Biogen launches controversial campaign

Aduhelm’s makers Biogen and its partner Eisai are taking a page right out of a classic marketing playbook: Run an educational campaign directed at the consumer, one who is already worried about whether those lost keys or a hard-to-recall name is a sign of something grave.

Be First to Comment

    Leave a Reply

    %d bloggers like this: